• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Medicare, Novo Nordisk A/S, Obesity, Ozempic (Drug), Prices (Fares, Fees and Rates), United States Politics and Government
←Social Media Users Shut Down GOP Senator Over His Out-Of-Control Disasters Claim
Seth Meyers Wants Biden To Do 1 ‘Wicked’ Thing At Donald Trump’s Inauguration→

More posts

  • F.A.A. Briefly Halts JetBlue Departures After System Outage

  • Asian shares surge, echoing rally on Wall Street as oil prices sank back to about $90

  • Who is Iran’s new supreme leader?

  • Fed Up With High Costs, American Theater Takes a Trip to London

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube